Price Move History
- Daily moves over 5%
- 10 20 sessions, May 11, 2026 to September 11, 2026
- Largest daily move
- +36.4% close of August 20, 2026
Company Description
SCIENTIST HOME FTR HLTH (OTC: SHFH) is classified in the pharmaceutical retailers industry within the Healthcare sector and carries a market capitalization of $244.3M.
SHFH has gained 8.4% over the past week. The last closing price was $10.30.
For FY2025, SCIENTIST HOME FTR HLTH reported revenue of $204K with net income of -$232K and diluted earnings per share of -$0.01. The company operates at a net profit margin of -113.6%.
This page collects what Stock Titan holds for SHFH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SCIENTIST HOME FTR HLTH (SHFH) closed at $10.30 on September 11, 2026. Over the past week, the price has gained 8.4%.
SHFH Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
SCIENTIST HOME FTR HLTH has filed 3 recent SEC filings, including 2 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on August 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SHFH SEC filings →
Financial Highlights
SCIENTIST HOME FTR HLTH generated $204K in revenue in FY2025, retaining a 40.1% gross margin, operating income reached -$232K (-113.6% operating margin), and net income was -$232K, reflecting a -113.6% net profit margin. Diluted earnings per share stood at -$0.01. The company generated -$248K in operating cash flow. With a current ratio of 0.90, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
SHFH Company Profile & Sector Positioning
SCIENTIST HOME FTR HLTH (SHFH) operates in the Pharmaceutical Retailers industry within the broader Healthcare sector and is listed on the OTC.